photo-teva-2
Photo: Courtesy of Teva
13 June 2016Americas

Teva prevails in Treanda validity dispute

Teva Pharmaceutical announced last Friday, June 10, that the US District Court for the District of Delaware ruled that four patents for the Treanda (bendamustine hydrochloride) injection are valid.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk